Case Studies from across the Catapults
- Skills (11),
- Levelling up (18),
- Highlights (27),
- Equality, Diversity and Inclusion (12),
- International (12),
- Academic engagement (19),
- Net Zero (23),
- Health (18),
- Digital technologies (18),
- Business growth (29),
- Supply chains (6),
- Leveraging Investment (19),
Themes (Reset)
- Skills
- Levelling up
-
Highlights
- Equality, Diversity and Inclusion
- International
- Academic engagement
-
More
Driving growth and prosperity across UK innovation
We form a crucial link in the UK’s rich innovation ecosystem – helping organisations to demonstrate and de-risk their innovation strategies and to build internal capability that attracts further investment, creates jobs, trade and sustainable prosperity.
We work across multiple sectors such as health, net zero, digitisation and are building partnerships that helping the UK to fight dementia and cancer, power electric vehicles, deliver 5G, drive low-carbon technologies from home heating to wind energy, create opportunities from space orbit data, create systems and places that enhance quality of life and so much more.
Take a look at a few examples of how Catapults are making a difference.
- Cross-Catapult (2),
- Cell and Gene Therapy (17),
- Compound Semiconductor Applications (13),
- Connected Places (15),
- Digital (16),
- Energy Systems (16),
- High Value Manufacturing (18),
- Medicines Discovery (16),
- Offshore Renewable Energy (16),
- Satellite Applications (15),
Catapults
Cell and Gene Therapy
Case Study
Upskilling the UK to take full advantage of the potential of cell and gene therapies
Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world’s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.
Cell and Gene Therapy
Case Study
Delivering safer advanced therapies, faster and at lower cost through technology and process innovation
At its core, Cell and Gene Therapy Catapult is an innovation and technology company. Its work with industry in the development of novel processes and analytical techniques for cell and gene therapy manufacture has supported significant investment into startup businesses as well as attracting international manufacturers such as Rentschler to invest in manufacturing in the UK.
Cell and Gene Therapy
Case Study
Establishing Stevenage as a global leader for cell and gene therapies
UK Government invested £72m in the Cell and Gene Therapy Catapult centre in Stevenage. This has led to the creation of one of the leading cell and gene therapy clusters globally and brought £1.5bn to the region through the 45 companies that are now investing there.
Compound Semiconductor Applications
Case Study
Identifying new opportunities to increase international trade in telecoms
In 2020 Compound Semiconductor Applications Catapult identified sizeable markets for the UK compound semiconductor industry to address, from the immediate opportunity rapid rollout of 5G and the longer term opportunities in quantum and satellite communications.
Connected Places
Case Study
Catalysing the future of flight
Connected Places Catapult is working at the leading edge of opportunity and innovation in aviation, spanning areas such as unscrewed air mobility, digitising airspace management and Zero Emission Flight.
Connected Places
Case Study
Stimulating investment in decarbonisation of UK cities
The Connected Places Catapult is leading a world-first alliance across the UK’s major cities to secure the long-term finance necessary for achieving net zero. The Cities Climate Investment Commission (3Ci) is helping cities to attract public and private sources of financing for a £300bn+ market opportunity for a multi-intervention place-based Net Zero transition.
Connected Places
Case Study
Sparking an innovation cluster in the Belfast City Region
Connected Places Catapult has been supporting place leaders in Belfast to create new opportunities for businesses since 2016, resulting in a successful bid for a City Region Deal which is forecast to deliver £2 billion in additional GVA and 10,000 new jobs.
Digital
Case Study
Trailblazing 5G festival hosted in the UK
The award-winning 5G Festival saw 20 musicians play together seamlessly, despite being in venues many miles apart, providing a glimpse of the massive potential of 5G technology.
Energy Systems
Case Study
Decarbonising homes: smart, low carbon solutions
Energy Systems Catapult (ESC) has pioneered the use of digital technology to help companies develop innovative low carbon heating offers that work for consumers. This has led to the creation of a 1,500+ home ‘Living Lab’ where companies can rapidly test their smart home innovations with real consumers.
Energy Systems
Case Study
Digitalising the energy system
Energy Systems Catapult (ESC) has been at the centre of a huge collaborative effort with industry, Government and the regulator to unlock the potential of digital technology and data to transform the energy system. This includes introducing an open data approach and harnessing digital technology to create jobs, growth and new consumer-friendly market propositions.
High Value Manufacturing
Case Study
Industrial transformation
High Value Manufacturing Catapult has a proven track record in regenerating areas left behind by industrial change and has achieved genuine levelling up.
High Value Manufacturing
Case Study
One of the nation’s largest providers of apprenticeships
The commitment of High Value Manufacturing Catapult and its Centres to equip the UK manufacturing sector with the skills it needs now and in the future is underlined with its apprentice offerings and support for national skills programmes.
Medicines Discovery
Case Study
Alchemab Therapeutics secures private funding for new treatments following collaboration
In 2021 Alchemab and Medicines Discovery Catapult (MDC) collaborated on a Huntington’s disease focussed project, which supported Alchemab in securing significant private investment.
Medicines Discovery
Case Study
The Psychiatry Consortium – exploring new treatments for mental health conditions
Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.
Page 1 of 2